Compare COLL & EVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COLL | EVEX |
|---|---|---|
| Founded | 2002 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2015 | N/A |
| Metric | COLL | EVEX |
|---|---|---|
| Price | $45.76 | $3.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $51.17 | $6.88 |
| AVG Volume (30 Days) | 406.2K | ★ 1.2M |
| Earning Date | 02-26-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $757,067,000.00 | N/A |
| Revenue This Year | $26.17 | N/A |
| Revenue Next Year | $3.65 | N/A |
| P/E Ratio | $28.17 | ★ N/A |
| Revenue Growth | ★ 26.34 | N/A |
| 52 Week Low | $23.23 | $2.83 |
| 52 Week High | $50.79 | $7.70 |
| Indicator | COLL | EVEX |
|---|---|---|
| Relative Strength Index (RSI) | 46.77 | 23.01 |
| Support Level | $43.99 | $3.21 |
| Resistance Level | $49.31 | $3.88 |
| Average True Range (ATR) | 1.62 | 0.22 |
| MACD | -0.12 | -0.09 |
| Stochastic Oscillator | 38.19 | 1.57 |
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.